We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Novartis Vaccines & Diagnostics Selects Partner in Enterprise Innovation and Collaboration

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

GlobalEnglish offers a solution to increase global companies' abilities to communicate and collaborate using Business English worldwide, leading to improved workforce productivity.

With an emphasis on innovative research and a strong commitment to preventing disease, Novartis Vaccines & Diagnostics, a division of Novartis, has led the healthcare industry with its global presence. Based in Italy, the division operates in more than 15 countries with more than 5000 employees representing nearly 50 different nationalities. In this environment, the ability for employees to communicate and collaborate effectively and efficiently in one common language -- Business English -- is vital to sustaining the success of Novartis' Vaccines & Diagnostics global operations and to advancing healthcare innovation.

In today's global economy, multinational organizations urgently need a way for globally dispersed teams to put their Business English skills to work immediately and to collaborate with each other on a common platform. 70 percent of learning is done while working according to research by Michael M. Lombardo and Robert W. Eichinger for the Center for Creative Leadership. On-the-job and socially-driven training lets employees learn while doing, diminishing company investment, increasing critical job skills more rapidly, and driving better organizational performance.

"At Novartis Vaccines & Diagnostics, we engage in high-stakes research and testing, and are responsible for 60 percent of Novartis Group's total vaccine production," says Gianluca Magnani, Director of Human Resources at Novartis Vaccines & Diagnostics. "The need to communicate efficiently and accurately is vital for the success of our company. It makes sense that we would offer GlobalEnglish's Business English support tools to each employee to enhance communications across departments and functions."

Novartis Vaccines & Diagnostics has quickly grown to become a leading employer of choice in the pharmaceutical industry, and has won recognition for being one of Europe's best places to work by Fortune, Institute Italia, The Scientist, and many others. This leadership position is largely due to the Company offering employees the tools they need to fluidly work together.

"Our mission is to empower our employees by providing them with the necessary tools to do their jobs more effectively," states Gianluca. "GlobalEnglish has given us an opportunity to provide our entire organization with the tools to help us grow, prosper, and succeed."

GlobalEnglish offers complete support for global teams who collaborate across countries, cultures and time zones by providing targeted resources that increase employees' overall Business English proficiency as well as on-demand performance support tools that improve day-to-day productivity by helping employees instantly use English on the job.

"We are honored to partner with Novartis Vaccines & Diagnostics, a progressive company that understands the current and future demands of global business and the strategic solutions necessary to maintain a competitive edge," says Tom Kahl, President of GlobalEnglish Corporation. "Improving communication and collaboration across the globally integrated enterprise increases productivity and performance and produces massive ROI thanks to the time and money saved on individual tasks -- that's Enterprise Fluency™."